tradingkey.logo
tradingkey.logo
Search

bioAffinity Technologies Inc

BIAF
Add to Watchlist
0.638USD
-0.006-0.95%
Close 07-31 16:00ETQuotes delayed by 15 min
2.21MMarket Cap
LossP/E TTM

BIAF Cash Flow Statement

You can access the annual and quarterly cash flow statements of bioAffinity Technologies Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q2
FY2021Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-96.57%-3.23M
-52.61%-2.56M
-45.11%-2.48M
-72.75%-2.65M
30.02%-1.64M
-3.77%-1.68M
-11.53%-1.71M
-12.68%-1.53M
-53.43%-2.35M
-24.27%-1.62M
12.93%-1.53M
-261.55%-1.36M
-141.19%-1.53M
---1.30M
---1.76M
-3.72%-376.14K
-61.50%-633.97K
---362.66K
---392.55K
Net income from continuing operations
-36.47%-3.63M
-5.75%-3.14M
-152.45%-5.05M
-92.43%-4.06M
-35.61%-2.66M
-25.02%-2.97M
12.66%-2.00M
-21.27%-2.11M
-27.99%-1.96M
-41.72%-2.37M
53.43%-2.29M
-1876.30%-1.74M
-4.13%-1.53M
---1.67M
---4.92M
-105.95%-88.05K
-105.54%-1.47M
--1.48M
---716.18K
Operating gains losses
-25.92%114.52K
-19.51%123.66K
-25.08%113.36K
-25.05%113.23K
3.31%154.59K
3.26%153.63K
162.81%151.30K
600.99%151.07K
590.05%149.64K
1929.84%148.79K
7347.48%57.57K
1972.21%21.55K
1987.10%21.68K
--7.33K
--773.00
-12.61%1.04K
-36.72%1.04K
--1.19K
--1.64K
Other non-cash items
----
-16.59%128.15K
--126.87K
----
----
--153.63K
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--82.68K
--767.69K
106.18%14.78K
--978.22K
---239.20K
--0.00
Change in working capital
-48.92%274.51K
-56.97%388.13K
-687.07%-357.17K
-81.56%25.93K
165.74%537.44K
141.46%902.02K
-108.82%-45.38K
-25.38%140.59K
-365.69%-817.51K
51.18%373.56K
169.32%514.36K
-58.33%188.42K
-211.85%-175.55K
--247.09K
---742.04K
140.46%452.20K
3.08%156.94K
--188.06K
--152.26K
-Change in receivables
-181.66%-143.27K
-149.46%-92.97K
-110.10%-27.12K
214.80%541.88K
156.25%175.46K
-21.53%187.96K
77.10%268.46K
-495.94%-472.02K
-57880.48%-311.94K
42949.02%239.53K
7273.83%151.58K
-8185.04%-79.20K
89.91%-538.00
---559.00
---2.11K
---956.00
-769.66%-5.33K
--0.00
---613.00
-Change in inventory
-117.82%-24.34K
-715.77%-18.31K
98.34%8.74K
74.41%-5.19K
-224.20%-11.17K
73.82%-2.25K
2182.38%4.41K
-1743.52%-20.28K
255.25%9.00K
-5000.57%-8.58K
432.76%193.00
745.21%1.23K
0.14%-5.79K
--175.00
---58.00
--146.00
---5.80K
--0.00
--0.00
-Change in prepaid expenses
520.57%40.00K
-450.69%-59.73K
67.77%-60.04K
-73.44%23.26K
126.99%6.45K
-72.37%17.03K
-89.09%-186.30K
-45.77%87.56K
-126.58%-23.88K
554.01%61.63K
79.21%-98.52K
509.27%161.44K
706.31%89.85K
--9.42K
---473.87K
26.46%-39.45K
2740.52%11.14K
---53.64K
---422.00
-Change in other current assets
6524.65%28.22K
-83.92%68.00
251.23%307.00
181.98%423.00
182.56%426.00
-94.28%423.00
---203.00
---516.00
---516.00
--7.40K
----
----
----
----
----
----
----
----
----
-Change in other current liabilities
---11.27K
--4.49K
--13.51K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-96.57%-3.23M
-52.61%-2.56M
-45.11%-2.48M
-72.75%-2.65M
30.02%-1.64M
-3.77%-1.68M
-11.53%-1.71M
-12.68%-1.53M
-53.43%-2.35M
-24.27%-1.62M
12.93%-1.53M
-261.55%-1.36M
-141.19%-1.53M
---1.30M
---1.76M
-3.72%-376.14K
-61.50%-633.97K
---362.66K
---392.55K
Investing cash flow
Net cash from continuing investing activities
-88.85%5.66K
0.00%1.00
-138.75%-3.65K
-52.53%13.43K
22.71%50.79K
100.01%1.00
5468.05%9.41K
632.58%28.29K
28.08%41.39K
-106.11%-13.44K
--169.00
--3.86K
--32.31K
--219.99K
----
----
----
----
----
Capital expenditures
-88.85%5.66K
0.00%1.00
----
-52.53%13.43K
22.71%50.79K
--1.00
5468.05%9.41K
632.58%28.29K
28.08%41.39K
----
--169.00
--3.86K
--32.31K
--219.99K
----
----
----
----
----
Net cash flow from disposal of fixed assets
-88.85%5.66K
0.00%1.00
-138.75%-3.65K
-52.53%13.43K
22.71%50.79K
100.01%1.00
5468.05%9.41K
632.58%28.29K
28.08%41.39K
-106.11%-13.44K
--169.00
--3.86K
--32.31K
--219.99K
----
----
----
----
----
Net cash flow from business transactions
----
----
----
----
----
--0.00
----
----
----
--0.00
---2.19M
----
----
----
----
----
----
----
----
Net cash flow from other investing activities
--0.00
--0.00
--0.00
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
88.85%-5.66K
0.00%-1.00
138.75%3.65K
52.53%-13.43K
-22.71%-50.79K
-100.01%-1.00
99.57%-9.41K
-632.58%-28.29K
-28.08%-41.39K
106.11%13.44K
---2.19M
---3.86K
---32.31K
---219.99K
----
----
----
----
----
Financing cash flow
Cash flow from continuous financing activities
-111.48%-118.51K
-33.85%1.34M
458.15%9.34M
3412.08%3.02M
-48.89%1.03M
2488.86%2.03M
3397.25%1.67M
27.72%-91.14K
2523.25%2.02M
84.95%-84.81K
-100.34%-50.77K
71.18%-126.10K
-127.65%-83.32K
---563.56K
--15.04M
-167.31%-437.49K
-43.91%301.36K
--650.00K
--537.26K
Net cash flow from debt Issuance/repayment
14.86%-118.51K
43.25%-106.65K
-74.76%43.13K
-82.93%-167.00K
-128.40%-139.19K
-101.58%-187.95K
436.54%170.85K
27.60%-91.29K
26.85%-60.94K
83.45%-93.24K
-107.18%-50.77K
-260.59%-126.10K
-117.54%-83.32K
---563.37K
--707.50K
-105.38%-34.97K
-11.59%475.00K
--650.00K
--537.26K
Net cash flow from common stock issuance/repurchase
----
-17.66%1.80M
3949.96%6.47M
--2.80M
----
--2.19M
--159.83K
--0.00
--2.00M
----
----
----
----
--0.00
--6.03M
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
--0.00
--990.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Proceeds from stock option exercised by employees
----
----
----
----
----
--0.00
--0.00
--0.00
--74.90K
----
----
----
----
--0.00
--74.90K
----
----
----
----
Proceeds from issuance of warrants
----
-98.97%285.00
142.34%3.26M
263442.18%387.41K
--1.17M
--27.77K
--1.34M
--147.00
----
----
----
----
----
--0.00
--7.71M
----
----
----
----
Net cash flow from other financing activities
--0.00
-264.75%-353.48K
---1.42M
----
----
-1249.19%-96.91K
----
----
----
4658.38%8.43K
-100.00%0.00
100.00%0.00
100.00%0.00
---185.00
--520.51K
---402.52K
---173.64K
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-111.48%-118.51K
-33.85%1.34M
458.15%9.34M
3412.08%3.02M
-48.89%1.03M
2488.86%2.03M
3397.25%1.67M
27.72%-91.14K
2523.25%2.02M
84.95%-84.81K
-100.34%-50.77K
71.18%-126.10K
-127.65%-83.32K
---563.56K
--15.04M
-167.31%-437.49K
-43.91%301.36K
--650.00K
--537.26K
Net cash flow
Beginning cash balance
483.54%6.45M
913.67%7.67M
0.19%802.84K
-81.87%444.71K
-60.83%1.11M
-83.22%756.58K
-90.32%801.31K
-74.89%2.45M
-75.28%2.82M
-66.59%4.51M
3761.49%8.28M
850.27%9.77M
738.85%11.41M
--13.50M
--214.40K
351.25%1.03M
1537.19%1.36M
--227.82K
--83.11K
Current period cash flow changes
-407.34%-3.35M
-449.69%-1.22M
15450.34%6.87M
121.68%358.13K
-79.31%-660.59K
120.66%348.71K
98.81%-44.73K
-10.87%-1.65M
77.60%-368.40K
19.02%-1.69M
-128.38%-3.77M
-83.12%-1.49M
-394.48%-1.64M
---2.08M
--13.28M
-383.16%-813.63K
-329.84%-332.60K
--287.34K
--144.71K
Ending cash balance
596.72%3.10M
483.54%6.45M
913.67%7.67M
0.19%802.84K
-81.87%444.71K
-60.83%1.11M
-83.22%756.58K
-90.32%801.31K
-74.89%2.45M
-75.28%2.82M
-66.59%4.51M
3761.49%8.28M
850.27%9.77M
--11.41M
--13.50M
-58.38%214.40K
351.25%1.03M
--515.16K
--227.82K
Free cash flow
-91.01%-3.23M
-52.61%-2.56M
----
-70.48%-2.66M
29.10%-1.69M
-3.77%-1.68M
-12.13%-1.72M
-14.44%-1.56M
-52.90%-2.39M
-6.29%-1.62M
---1.53M
---1.36M
---1.56M
---1.52M
----
----
----
----
----
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

What is operating cash flow?

Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did bioAffinity Technologies Inc Generate?

bioAffinity Technologies Inc generated -9.33M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did bioAffinity Technologies Inc's Operating Cash Flow Change Year Over Year?

bioAffinity Technologies Inc's operating cash flow increased by -28.41% year over year.

What is investing cash flow?

Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does bioAffinity Technologies Inc Spend on Capital Expenditures?

bioAffinity Technologies Inc spent 60.57K on capital expenditures in the most recent quarter。

What is financing cash flow?

Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has bioAffinity Technologies Inc's Financing Cash Flow Changed?

bioAffinity Technologies Inc used 14.73M in financing activities in the latest quarter.

What is free cash flow and why does it matter for BIAF?

Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was bioAffinity Technologies Inc’s free cash flow in the latest quarter?

Free cash flow was -9.39M reflecting a -27.85% change from the previous year.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.